Amount Raised
$42.3 Million
Round Type
Funding Round
TaiwanBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announces that it has successfully completed an underwritten public offering of 17,500,000 shares of its common stock to the public at a price of NT$75 per share. The aggregate gross proceeds to Foresee from the offering were NT$1,312.5 million (or US$42.3 million at FX=31).
Who to call at Foresee Pharmaceuticals, and when
A new round usually means Foresee Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Foresee Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Foresee Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Foresee Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Foresee Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Foresee Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.